LONN.VX - Lonza Group Ltd

Swiss - Swiss Delayed price. Currency in CHF
+3.70 (+1.52%)
At close: 5:30PM CET
Stock chart is not supported by your current browser
Previous close242.70
Bid222.90 x 60500
Ask229.00 x 66200
Day's range244.00 - 246.60
52-week range164.23 - 278.40
Avg. volume356,206
Market cap18.318B
PE ratio (TTM)23.25
EPS (TTM)10.60
Earnings dateN/A
Forward dividend & yield1.76 (3.02%)
Ex-dividend date2014-04-22
1y target est288.30
  • Reuters - UK Focus17 days ago

    Lonza upbeat on outlook, but margin growth forecast hits shares

    Lonza forecast a 2018 operating profit margin that fell short of market expectations on Wednesday, knocking the Swiss drug ingredients maker's shares despite its 2017 earnings beating predictions. Shares (Berlin: DI6.BE - news) in Lonza, which makes molecules for drug companies such as Roche as well as ingredients for nutritional supplements, were down 3.8 percent to 264.70 Swiss francs at 1305 GMT. Some analysts said they were underwhelmed by Chief Executive Richard Ridinger's goal for achieving a 100 basis point improvement in core margin for earnings before interest, taxes, depreciation and amortisation (EBITDA).

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes